5 things to know about the global orthobiologics market

Written by Shayna Korol | September 27, 2018 | Print  |

The global orthobiologics market is projected to grow at a 3.5 percent compound annual growth rate, topping $6.5 billion by 2027, according to a Future Market Insights report.

Here are five things to know:

1. In North America, the orthobiologics market is expected to reach more than $3 billion by 2027.

2. The bone graft stimulators segment holds the largest market share and is expected to exceed $3 billion by 2027.

3. The increasing incidence of fracture-causing orthopedic disorders and sports injuries, as well as the rising demand for outpatient surgical procedures and increasing medical tourism, are driving the global orthobiologics market forward.

4. The high cost of orthopedic surgery and increasing competition leading to price fluctuations are limiting the global market's growth.

5. Key players in the global orthobiologics market include:

  • Medtronic
  • NuVasive
  • Stryker
  • Zimmer Biomet
  • Orthofix

More articles on biologics:
Kuros Biosciences appoints 5 spine surgeons to advisory board
Orthopedic surgeon named Reinvent Biologics' CMO: 3 insights
Human skeletal stem cells identified, may have therapeutic potential: 4 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months